Reduced salivary amylase activity in metabolic syndrome patients with obesity could be improved by treatment with a dipeptidyl peptidase IV inhibitor
© 2018 Springer-Verlag GmbH Germany, part of Springer Nature Objectives: The present study is to investigate the salivary gland function of metabolic syndrome (MetS) patients, as indicated by salivary flow rate, amylase activity, and salivary oxidative stress, by measuring MDA level. Materials and m...
Saved in:
| Main Authors: | , , , |
|---|---|
| 格式: | 雜誌 |
| 出版: |
2018
|
| 在線閱讀: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85043368412&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/48480 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|